THE DEAL, AT A GLANCE
From the announcementFathom Therapeutics
01Who is involvedBacked by Sutter Hill VenturesFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02What happenedFathom Therapeutics raised $55M Series A, announced 2026-11-09From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03Why it mattersFathom Therapeutics raised a $55M Series A led by Sutter Hill Ventures to advance AI drug discovery.From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Fathom Therapeutics · Financing Record
Explore source-linked visual explanations for Fathom Therapeutics. Unsupported claims are withheld while source review continues.
Record 15678 · Recorded date: 2026-11-09
What it does
Unsupported business claims are withheld pending source review. Explore the linked records for available evidence.
Explore company records →